Early Phase 1 Idiopathic Pulmonary Fibrosis Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
Idiopathic Pulmonary Fibrosis
Shanghai Synvida Biotechnology Co.,Ltd.53 enrolled1 locationNCT06267183
Recruiting
Early Phase 1
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
University of Virginia6 enrolled1 locationNCT06853145
Recruiting
Early Phase 1
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).
Idiopathic Pulmonary Fibrosis
Dr. Denis O'Donnell40 enrolled1 locationNCT05052229
Completed
Early Phase 1
A Single Microdose Study to Evaluate the Pharmacokinetics of INS018_055 in Healthy Participants
Idiopathic Pulmonary Fibrosis (IPF)
Insilico Medicine Hong Kong Limited8 enrolled1 locationACTRN12621001541897